Pharmaceutical Clinical Educators: A Resource for Advanced Practice Providers
Sheila Adams Arrington,(1) MSN, GNP-BC, AOCN®, Laurie A. Farrell,(2) MSN, ARNP,
FNP-C, and Joanne Henning,(3) ANP-BC
1)Genentech, a Member of the Roche Group, Germanton, North Carolina; 2)Genentech, a Member of the Roche Group, Kissimmee, Florida; 3)Genentech, a Member of the Roche Group, Collegeville, Pennsylvania
Authors’ disclosures of conflicts of interest are found at the end of this article.
Sheila Adams Arrington, MSN, GNP-BC, AOCN®, 3582 NC 8 and 65 Hwy, Germanton, NC 27019. E-mail: email@example.com
J Adv Pract Oncol 2018;9(1):86–89 |
© 2018 Harborside™
One of the main challenges within clinical practice today involves attaining the knowledge necessary to treat patients safely and effectively. The explosion of scientific breakthroughs within the health-care setting has created a new challenge for today’s practitioners: staying informed. In turn, the pharmaceutical industry has been challenged with providing information that is accurate, meaningful, and compliant with US Food and Drug Administration guidelines. In this article, we review how the pharmaceutical industry has tried to fill this need through the role of the pharmaceutical clinical educator (PCE). We describe the PCE role and the different forms of education and support that can be provided to advanced practice providers (APPs). We also address the conflict of interest issues surrounding a collaborative relationship between APPs and pharmaceutical industry APPs.
For access to the full length article, please sign in